Pharmaceuticals Ultrasector Profund Fund Quote
| PHPIX Fund | USD 23.91 0.38 1.56% |
PerformanceVery Weak
| Odds Of DistressLow
|
Pharmaceuticals Ultrasector is trading at 23.91 as of the 28th of March 2025; that is 1.56 percent down since the beginning of the trading day. The fund's open price was 24.29. Pharmaceuticals Ultrasector has about a 22 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 28th of December 2024 and ending today, the 28th of March 2025. Click here to learn more.
The fund invests in financial instruments that the fund Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index represents the pharmaceuticals segment of the SP Total Market Index, which comprises the following sub-industry pharmaceuticals. More on Pharmaceuticals Ultrasector Profund
Moving against Pharmaceuticals Mutual Fund
Pharmaceuticals Mutual Fund Highlights
| Fund Concentration | ProFunds Funds, Large Funds, Trading--Leveraged Equity Funds, Trading--Leveraged Equity, ProFunds, Large, Trading--Leveraged Equity (View all Sectors) |
| Update Date | 31st of March 2025 |
| Expense Ratio Date | 30th of November 2022 |
| Fiscal Year End | July |
Pharmaceuticals Ultrasector Profund [PHPIX] is traded in USA and was established 28th of March 2025. Pharmaceuticals Ultrasector is listed under ProFunds category by Fama And French industry classification. The fund is listed under Trading--Leveraged Equity category and is part of ProFunds family. This fund at this time has accumulated 3.27 M in assets with no minimum investment requirementsPharmaceuticals Ultrasector is currently producing year-to-date (YTD) return of 2.11% with the current yeild of 0.01%, while the total return for the last 3 years was -5.37%.
Check Pharmaceuticals Ultrasector Probability Of Bankruptcy
Instrument Allocation
Top Pharmaceuticals Ultrasector Profund Mutual Fund Constituents
| BMY | Bristol Myers Squibb | Stock | Health Care | |
| ELAN | Elanco Animal Health | Stock | Health Care | |
| JNJ | Johnson Johnson | Stock | Health Care | |
| LLY | Eli Lilly and | Stock | Health Care | |
| MRK | Merck Company | Stock | Health Care | |
| PFE | Pfizer Inc | Stock | Health Care | |
| ZTS | Zoetis Inc | Stock | Health Care | |
| PRGO | Perrigo Company PLC | Stock | Health Care |
Pharmaceuticals Ultrasector Risk Profiles
Pharmaceuticals Ultrasector Against Markets
Other Information on Investing in Pharmaceuticals Mutual Fund
Pharmaceuticals Ultrasector financial ratios help investors to determine whether Pharmaceuticals Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmaceuticals with respect to the benefits of owning Pharmaceuticals Ultrasector security.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |